(571) 447-5500

Natural Products Insider published an article on the possibility of an FDA regulatory pathway for CBD products. EAS independent consultant and GRAS/NDI expert toxicologist, Tom Jonaitis is one of the experts quoted. Read more. Should you have interest in considering a GRAS or NDI submission for your ingredients, contact EAS to develop a regulatory and submissions strategy.

Posted in Cosmetics, EAS in Action, EAS in the News Cannabis.